Evidence map›Paper›PMID 39955092›Full record

ArticleThe Journal of rheumatology2025

Unveiling the Dual Benefits of Bosentan in Systemic Sclerosis: Risk and Relief.

Matthew R Lammi, Monica Mukherjee

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew R LammiM.R. Lammi, MD, Johns Hopkins University School of Medicine Divisions of Pulmonary and Critical Care Medicine, Baltimore.ORCID https://orcid.org/0000-0001-5125-1801
Monica MukherjeeM. Mukherjee, MD, MPH, Johns Hopkins University School of Medicine Divisions of Pulmonary and Critical Care Medicine, and Division of Cardiology, Baltimore, Maryland, USA. mmukher2@jhu.edu.ORCID https://orcid.org/0000-0001-6088-0773

Funding

Early Detection of Right Ventricular Dysfunction and Emerging Pulmonary Hypertension in Systemic SclerosisR01HL162851 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Monica Mukherjee · 2023 to 2026
$2.5M
Unsupervised Machine Learning to Identify Unique Clusters of Systemic Sclerosis Pulmonary Hypertension PatientsR21HL172119 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI LAMMI, MATTHEW R · 2025 to 2025
$246k
NHLBI NIH HHS R01 HL162851NHLBI NIH HHS R21 HL172119
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39955092
PMCPMC12026298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.